Seer awarded $1m grant for personalised epilepsy seizure forecasting app

Media Statement

Melbourne-headquartered medical technology company Seer has been awarded a $1m grant for the development of an app that produces a personalised epilepsy seizure forecast.

Funded by the Australian Government through the BioMedTech Horizons program, and operated by MTPConnect, Seer’s digital innovation combines a mobile app with integrated wearable devices. Seer’s co-founder and CEO, Dr Dean Freestone, said that Seer was departing from the long-standing approach to research into seizure forecasting that focused on brain activity alone.

To read the full media statement, click here.